MNTC Overzicht aandelen
Mentice AB (publ) levert endovasculaire simulatietechnologieoplossingen in Europa, het Midden-Oosten, Afrika, Azië, de regio Azië-Pacific en Noord- en Zuid-Amerika.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 4/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 0/6 |
Mentice AB (publ) Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | SEK 28.60 |
| 52 Week Hoogtepunt | SEK 71.40 |
| 52 Week Laag | SEK 24.70 |
| Bèta | 1.06 |
| 11 maand verandering | 6.32% |
| 3 maanden verandering | -4.98% |
| 1 Jaar Verandering | -14.63% |
| 33 jaar verandering | -73.64% |
| 5 jaar verandering | -71.31% |
| Verandering sinds IPO | -57.69% |
Recent nieuws en updates
Mentice AB (publ)'s (STO:MNTC) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors
Aug 31
Mentice AB (publ) Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jul 26Investors Still Waiting For A Pull Back In Mentice AB (publ) (STO:MNTC)
Jul 11Recent updates
Mentice AB (publ)'s (STO:MNTC) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors
Aug 31Mentice AB (publ) Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jul 26Investors Still Waiting For A Pull Back In Mentice AB (publ) (STO:MNTC)
Jul 11These Analysts Think Mentice AB (publ)'s (STO:MNTC) Sales Are Under Threat
May 09Mentice AB (publ) Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
May 08Mentice AB (publ) (STO:MNTC) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless
Feb 17Capital Allocation Trends At Mentice (STO:MNTC) Aren't Ideal
Feb 03Mentice AB (publ)'s (STO:MNTC) Shares Climb 29% But Its Business Is Yet to Catch Up
Jan 03Is There An Opportunity With Mentice AB (publ)'s (STO:MNTC) 45% Undervaluation?
Dec 21Mentice (STO:MNTC) Will Be Hoping To Turn Its Returns On Capital Around
Oct 04Is There An Opportunity With Mentice AB (publ)'s (STO:MNTC) 42% Undervaluation?
Jan 31Mentice AB (publ) (STO:MNTC) Shares Could Be 44% Below Their Intrinsic Value Estimate
Jun 15Why Mentice AB (publ) (STO:MNTC) Could Be Worth Watching
Apr 19Mentice AB (publ)'s (STO:MNTC) Intrinsic Value Is Potentially 59% Above Its Share Price
Feb 01Is Mentice AB (publ) (STO:MNTC) Potentially Undervalued?
Nov 22Does This Valuation Of Mentice AB (publ) (STO:MNTC) Imply Investors Are Overpaying?
Oct 06Companies Like Mentice (STO:MNTC) Can Afford To Invest In Growth
Sep 03We're Not Very Worried About Mentice's (STO:MNTC) Cash Burn Rate
May 03Calculating The Intrinsic Value Of Mentice AB (publ) (STO:MNTC)
Mar 22Could The Mentice AB (publ) (STO:MNTC) Ownership Structure Tell Us Something Useful?
Feb 15Did Mentice's (STO:MNTC) Share Price Deserve to Gain 10%?
Jan 18Need To Know: Mentice AB (publ) (STO:MNTC) Insiders Have Been Buying Shares
Dec 28
Are Investors Undervaluing Mentice AB (publ) (STO:MNTC) By 20%?
Dec 07Rendement voor aandeelhouders
| MNTC | SE Healthcare Services | SE Markt | |
|---|---|---|---|
| 7D | 1.8% | -3.7% | -2.3% |
| 1Y | -14.6% | 41.2% | 21.0% |
Rendement versus industrie: MNTC underperformed the Swedish Healthcare Services industry which returned 41.2% over the past year.
Rendement versus markt: MNTC underperformed the Swedish Market which returned 21% over the past year.
Prijsvolatiliteit
| MNTC volatility | |
|---|---|
| MNTC Average Weekly Movement | 5.0% |
| Healthcare Services Industry Average Movement | 5.0% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in SE Market | 10.8% |
| 10% least volatile stocks in SE Market | 3.2% |
Stabiele aandelenkoers: MNTC has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatiliteit in de loop van de tijd: MNTC's weekly volatility (5%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1998 | 134 | Göran Malmberg | www.mentice.com |
Mentice AB (publ) levert endovasculaire simulatietechnologieoplossingen in Europa, het Midden-Oosten, Afrika, Azië, de regio Azië-Pacific en Noord- en Zuid-Amerika. Het bedrijf is actief in drie segmenten: Systemen, Softwarelicenties en Service. Het bedrijf biedt softwaremodules op het gebied van acute ischemische beroerteinterventie, atriumseptumdefect- en patent foramen ovale-occlusie, aortaklepimplantatie, endovasculair aortareparatie, interventie onder de knie, carotisinterventie, patiëntspecifieke simulatie, coronaire geavanceerde, essentiële en intermediaire interventie, occlusie van de linkerhartboezem, neurovasculaire coiling en trombectomie, perifere angiografie, embolisatie van de prostaatslagader, stralingsveiligheid, renale denervatie, renale interventie, thoracaal endovasculair aortair herstel, transarteriële chemo-embolisatie, transseptale punctie, embolisatie van de baarmoederslagader, perifere angiografie en vasculair trauma en hartritmemanagement, en ondersteunt interventionisten bij de overgang van transfemorale naar transradiale toegang.
Mentice AB (publ) Samenvatting
| MNTC fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | SEK 731.27m |
| Inkomsten(TTM) | -SEK 10.20m |
| Inkomsten(TTM) | SEK 280.53m |
2.6x
P/S-verhouding-71.7x
Koers/WinstverhoudingIs MNTC overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| MNTC resultatenrekening (TTM) | |
|---|---|
| Inkomsten | SEK 280.53m |
| Kosten van inkomsten | SEK 35.71m |
| Brutowinst | SEK 244.82m |
| Overige uitgaven | SEK 255.03m |
| Inkomsten | -SEK 10.20m |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
Nov 07, 2024
| Winst per aandeel (EPS) | -0.40 |
| Brutomarge | 87.27% |
| Nettowinstmarge | -3.64% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde MNTC op de lange termijn?
Bekijk historische prestaties en vergelijking